Literature DB >> 23375374

A comprehensive nuclear receptor network for breast cancer cells.

Ralf Kittler1, Jie Zhou, Sujun Hua, Lijia Ma, Yuwen Liu, Elisha Pendleton, Chao Cheng, Mark Gerstein, Kevin P White.   

Abstract

In breast cancer, nuclear receptors (NRs) play a prominent role in governing gene expression, have prognostic utility, and are therapeutic targets. We built a regulatory map for 24 NRs, six chromatin state markers, and 14 breast-cancer-associated transcription factors (TFs) that are expressed in the breast cancer cell line MCF-7. The resulting network reveals a highly interconnected regulatory matrix where extensive crosstalk occurs among NRs and other breast -cancer-associated TFs. We show that large numbers of factors are coordinately bound to highly occupied target regions throughout the genome, and these regions are associated with active chromatin state and hormone-responsive gene expression. This network also provides a framework for stratifying and predicting patient outcomes, and we use it to show that the peroxisome proliferator-activated receptor delta binds to a set of genes also regulated by the retinoic acid receptors and whose expression is associated with poor prognosis in breast cancer.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23375374     DOI: 10.1016/j.celrep.2013.01.004

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  42 in total

1.  Cancer progression modeling using static sample data.

Authors:  Yijun Sun; Jin Yao; Norma J Nowak; Steve Goodison
Journal:  Genome Biol       Date:  2014-08-26       Impact factor: 13.583

2.  Inhibition of cancer cell proliferation by PPARγ is mediated by a metabolic switch that increases reactive oxygen species levels.

Authors:  Nishi Srivastava; Rahul K Kollipara; Dinesh K Singh; Jessica Sudderth; Zeping Hu; Hien Nguyen; Shan Wang; Caroline G Humphries; Ryan Carstens; Kenneth E Huffman; Ralph J DeBerardinis; Ralf Kittler
Journal:  Cell Metab       Date:  2014-09-25       Impact factor: 27.287

Review 3.  Vitamin D receptor and RXR in the post-genomic era.

Authors:  Mark D Long; Lara E Sucheston-Campbell; Moray J Campbell
Journal:  J Cell Physiol       Date:  2015-04       Impact factor: 6.384

4.  Specificity landscapes unmask submaximal binding site preferences of transcription factors.

Authors:  Devesh Bhimsaria; José A Rodríguez-Martínez; Junkun Pan; Daniel Roston; Elif Nihal Korkmaz; Qiang Cui; Parameswaran Ramanathan; Aseem Z Ansari
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-19       Impact factor: 11.205

Review 5.  Nuclear receptors in cancer - uncovering new and evolving roles through genomic analysis.

Authors:  Vineet K Dhiman; Michael J Bolt; Kevin P White
Journal:  Nat Rev Genet       Date:  2017-12-27       Impact factor: 53.242

6.  Breast cancer prognosis predicted by nuclear receptor-coregulator networks.

Authors:  Tram B Doan; Natalie A Eriksson; Dinny Graham; John W Funder; Evan R Simpson; Elizabeth S Kuczek; Colin Clyne; Peter J Leedman; Wayne D Tilley; Peter J Fuller; George E O Muscat; Christine L Clarke
Journal:  Mol Oncol       Date:  2014-04-04       Impact factor: 6.603

7.  Pan-cancer analyses of the nuclear receptor superfamily.

Authors:  Mark D Long; Moray J Campbell
Journal:  Nucl Receptor Res       Date:  2015-12-15

8.  PPARδ induces estrogen receptor-positive mammary neoplasia through an inflammatory and metabolic phenotype linked to mTOR activation.

Authors:  Hongyan Yuan; Jin Lu; Junfeng Xiao; Geeta Upadhyay; Rachel Umans; Bhaskar Kallakury; Yuhzi Yin; Michael E Fant; Levy Kopelovich; Robert I Glazer
Journal:  Cancer Res       Date:  2013-06-27       Impact factor: 12.701

9.  GR and ER Coactivation Alters the Expression of Differentiation Genes and Associates with Improved ER+ Breast Cancer Outcome.

Authors:  Diana C West; Deng Pan; Eva Y Tonsing-Carter; Kyle M Hernandez; Charles F Pierce; Sarah C Styke; Kathleen R Bowie; Tzintzuni I Garcia; Masha Kocherginsky; Suzanne D Conzen
Journal:  Mol Cancer Res       Date:  2016-05-02       Impact factor: 5.852

10.  A Computational Drug Repositioning Approach for Targeting Oncogenic Transcription Factors.

Authors:  Kaitlyn M Gayvert; Etienne Dardenne; Cynthia Cheung; Mary Regina Boland; Tal Lorberbaum; Jackline Wanjala; Yu Chen; Mark A Rubin; Nicholas P Tatonetti; David S Rickman; Olivier Elemento
Journal:  Cell Rep       Date:  2016-06-02       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.